title: Low trough serum infliximab and antibodies to infliximab in smokers.
authors.forename: Jee Yuen
authors.initials: JY
authors.lastname: Kong
authors.forename: Christine
authors.initials: C
authors.lastname: Bundell
authors.forename: Janina
authors.initials: J
authors.lastname: Pawlik
authors.forename: Peter
authors.initials: P
authors.lastname: Hollingsworth
authors.forename: Geoff
authors.initials: G
authors.lastname: Forbes
mesh_terms: D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood / Q000276:immunology* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000097:blood / Q000276:immunology* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D003424:Crohn Disease / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012907:Smoking / Q000009:adverse effects* / Q000276:immunology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab